Royal Arc Electrodes IPO subscribed 1.1 times so far on Day 3. Check GMP, price band and other details
Royal Arc Electrodes IPO: The retail portion of the issue was subscribed 1.39 times, while the non-institutional investors category saw a subscription of 66% on the final day of bidding. Meanwhile, qualified institutional buyers subscribed to 74% ...

The company aims to raise Rs 36 crore through the IPO, and the issue is a mix of fresh issue worth Rs 21.60 crore and an offer for sale (OFS) of Rs 14.40 crore.
The retail portion of the issue was subscribed by 1.39 times, while the issue was subscribed by 66% in the non-institutional investors category on the final day of bidding. Meanwhile, the qualified institutional buyers had subscribed by 74% of the allotted portion.
Royal Arc Electrodes IPO’s GMP on Day 3
Ahead of listing, the company's shares were trading with a GMP of Rs 0 in the unlisted market on Tuesday, indicating a nil premium over the upper end of the IPO price band of Rs 120.
Proceeds from IPO
The IPO proceeds will be used for funding towards the expansion of the existing manufacturing facility situated at village Zaroli, working capital requirements and general corporate purposes.
Royal Arc Electrodes IPO price band
The Royalarc Electrodes IPO is priced between Rs 114 and Rs 120 per share, with investors able to bid for a minimum of 1,200 shares per lot, and in multiples thereof.
Allotment and listing date
The allotment for the IPO is set for Wednesday, February 19, while the listing of the shares on the NSE SME platform is scheduled for Friday, February 21.
About Royalarc Electrodes IPO
Further, Royalarc is also engaged in the business of trading of ancillary/incidental products like abrasive wheels, welding flux,
Manufacturing is emerging as an integral pillar in the country’s economic growth, thanks to the performance of key sectors like automotive, engineering, chemicals, pharmaceuticals, and consumer durables.
Fedex Securities is the book-running lead manager of the Royalarc Electrodes IPO and Kfin Technologies is the registrar.
Also read | Chandan Healthcare shares list at 4% premium on NSE SME platform
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)
Download ET Markets APP